157 related articles for article (PubMed ID: 6307571)
1. Elevated antibody titers to Epstein-Barr virus and low natural killer cell activity in patients with Chediak-Higashi syndrome.
Merino F; Klein GO; Henle W; Ramirez-Duque P; Forsgren M; Amesty C
Clin Immunol Immunopathol; 1983 Jun; 27(3):326-39. PubMed ID: 6307571
[TBL] [Abstract][Full Text] [Related]
2. Chronic active Epstein-Barr virus infection in patients with Chediak-Higashi syndrome.
Merino F; Henle W; Ramírez-Duque P
J Clin Immunol; 1986 Jul; 6(4):299-305. PubMed ID: 3018035
[TBL] [Abstract][Full Text] [Related]
3. Epstein-Barr serology in immunodeficiencies: an attempt to correlate with immune abnormalities in Wiskott-Aldrich and Chediak-Higashi syndromes and ataxia telangiectasia.
Vilmer E; Lenoir GM; Virelizier JL; Griscelli C
Clin Exp Immunol; 1984 Feb; 55(2):249-56. PubMed ID: 6321070
[TBL] [Abstract][Full Text] [Related]
4. Brief report: killer cell defect and persistent immunological abnormalities in two patients with chronic active Epstein-Barr virus infection.
Joncas J; Monczak Y; Ghibu F; Alfieri C; Bonin A; Ahronheim G; Rivard G
J Med Virol; 1989 Jun; 28(2):110-7. PubMed ID: 2544675
[TBL] [Abstract][Full Text] [Related]
5. The accelerated phase of Chediak-Higashi syndrome. An expression of the virus-associated hemophagocytic syndrome?
Rubin CM; Burke BA; McKenna RW; McClain KL; White JG; Nesbit ME; Filipovich AH
Cancer; 1985 Aug; 56(3):524-30. PubMed ID: 2988747
[TBL] [Abstract][Full Text] [Related]
6. Chediak-Higashi syndrome: immunological responses to Epstein-Barr virus studies in gene heterozygotes.
Merino F; Amesty C; Henle W; Layrisse Z; Bianco N; Ramírez-Duque P
J Clin Immunol; 1986 May; 6(3):242-8. PubMed ID: 3013924
[TBL] [Abstract][Full Text] [Related]
7. Epstein-Barr virus (EBV)-specific cell-mediated and humoral immune responses in ataxia-telangectasia patients.
Masucci G; Berkel I; Masucci MG; Ernberg I; Szigeti R; Ersoy F; Sanal O; Yegin O; Henle G; Henle W
J Clin Immunol; 1984 Sep; 4(5):369-82. PubMed ID: 6092413
[TBL] [Abstract][Full Text] [Related]
8. Immune response to Epstein-Barr virus (EBV) in ataxia-telangiectasia: EBV-specific antibody patterns and their relation to cell-mediated immunity.
Berkel AI; Henle W; Henle G; Ersoy F; Sanal O; Klein G; Yeğin O
Kroc Found Ser; 1985; 19():287-300. PubMed ID: 2999343
[TBL] [Abstract][Full Text] [Related]
9. Immunological characterization of Hodgkin's and non-Hodgkin's lymphoma patients with high antibody titers against Epstein-Barr virus-associated antigens.
Masucci G; Mellstedt H; Masucci MG; Szigeti R; Ernberg I; Björkholm M; Tsukuda K; Henle G; Henle W; Pearson G
Cancer Res; 1984 Mar; 44(3):1288-300. PubMed ID: 6318984
[TBL] [Abstract][Full Text] [Related]
10. Epstein-Barr virus gp350-specific antibody titers and antibody-dependent cellular cytotoxic effector function in different groups of patients: a study using cloned gp350-expressing transfected human T cell targets.
Khyatti M; Stefanescu I; Blagdon M; Menezes J
J Infect Dis; 1994 Dec; 170(6):1439-47. PubMed ID: 7995983
[TBL] [Abstract][Full Text] [Related]
11. Hematologic and immunologic responses in common marmosets (Callithrix jacchus) infected with Plasmodium knowlesi and Epstein-Barr virus.
Felton SC; Hoffmann CC; Kreier JP; Glaser R
Lab Anim Sci; 1984 Apr; 34(2):164-8. PubMed ID: 6328114
[TBL] [Abstract][Full Text] [Related]
12. In vivo Epstein Barr virus-induced augmentation of natural killer cell activity in the Chédiak-Higashi syndrome.
Katz P; Zaytoun AM; Lee JH; Fauci AS
J Immunol; 1984 Feb; 132(2):571-3. PubMed ID: 6197464
[No Abstract] [Full Text] [Related]
13. [Studies on Epstein-Barr virus (EBV) infection and reactivity of peripheral B lymphocytes to EBV in patients with ataxia telangiectasia].
Okano M
Hokkaido Igaku Zasshi; 1986 Jul; 61(4):584-92. PubMed ID: 3019855
[TBL] [Abstract][Full Text] [Related]
14. Epstein-Barr virus infection in Chediak-Higashi syndrome mimicking acute lymphocytic leukemia.
Kinugawa N
Am J Pediatr Hematol Oncol; 1990; 12(2):182-6. PubMed ID: 2165746
[TBL] [Abstract][Full Text] [Related]
15. [The latent dysfunction of Epstein-Barr virus (EBV)-specific cellular immunity in asymptomatic human immunodeficiency virus (HIV) carriers].
Sugiura M
Hokkaido Igaku Zasshi; 1991 Sep; 66(5):694-708. PubMed ID: 1660017
[TBL] [Abstract][Full Text] [Related]
16. Increased incidence of IgA antibodies to the Epstein-Barr virus-associated viral capsid antigen and early antigens in patients with chronic lymphocytic leukemia.
Dölken G; Bross KJ; Hecht T; Brugger W; Löhr GW; Hirsch FW
Int J Cancer; 1986 Jul; 38(1):55-9. PubMed ID: 3013785
[TBL] [Abstract][Full Text] [Related]
17. Defective activity of Epstein-Barr virus (EBV) specific cytotoxic T lymphocytes in children with chronic active EBV infection and in their parents.
Fujieda M; Wakiguchi H; Hisakawa H; Kubota H; Kurashige T
Acta Paediatr Jpn; 1993 Oct; 35(5):394-9. PubMed ID: 8256622
[TBL] [Abstract][Full Text] [Related]
18. Epstein-Barr virus infection and immunologic dysfunction in patients with aqueous tear deficiency.
Pflugfelder SC; Tseng SC; Pepose JS; Fletcher MA; Klimas N; Feuer W
Ophthalmology; 1990 Mar; 97(3):313-23. PubMed ID: 2159609
[TBL] [Abstract][Full Text] [Related]
19. Epstein-Barr virus-infected B cells of males with the X-linked lymphoproliferative syndrome stimulate and are susceptible to T-cell-mediated lysis.
Jäger M; Benninger-Döring G; Prang N; Sylla BS; Laumbacher B; Wank R; Wolf H; Schwarzmann F
Int J Cancer; 1998 May; 76(5):694-701. PubMed ID: 9610728
[TBL] [Abstract][Full Text] [Related]
20. Longitudinal study of Epstein-Barr virus antibody titers and excretion in pediatric patients with Hodgkin's disease.
Lange B; Arbeter A; Hewetson J; Henle W
Int J Cancer; 1978 Nov; 22(5):521-7. PubMed ID: 82539
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
